日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

DESTINY-Breast08: A Phase Ib Study of Trastuzumab Deruxtecan in Combination with Other Anticancer Therapies in Patients with HER2-Low Metastatic Breast Cancer

DESTINY-Breast08：曲妥珠单抗德鲁替康联合其他抗癌疗法治疗HER2低表达转移性乳腺癌患者的Ib期研究

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-0874
Jhaveri, Komal; Loi, Sherene; Hamilton, Erika; Schmid, Peter; Anders, Carey K; Testa, Laura; Wildiers, Hans; Tseng, Ling-Ming; Lu, Yen-Shen; Park, Yeon Hee; Im, Seock-Ah; Chen, Shin-Cheh; Young, Robyn R; Lloyd, Caron; Wrona, Magdalena; Zhang, Cuihong; Carroll, Danielle; André, Fabrice
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Application of CTC-derived spheroid for drug screening toward personalized treatment in patients with breast cancer

将CTC衍生球体应用于乳腺癌患者的个体化治疗药物筛选

期刊:Translational Oncology
影响因子:4.1
doi:10.1016/j.tranon.2025.102573
Chou, Hsu-Huan; Che, Ting-Fang; Lee, Kuan-Ju; Chen, Shin-Cheh; Chen, Jia-Yang; Huang, Yen-Jang; Lim, Syer Choon; Huang, Shih-Chiang; Tsai, Chia-Lung; Chang, Ying-Chih; Tsai, Chi-Neu
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort

Capivasertib联合氟维司群治疗HR阳性/HER2阴性晚期乳腺癌患者：3期CAPItello-291研究扩展中国队列

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-59210-6
Hu, Xichun; Zhang, Qingyuan; Sun, Tao; Xiong, Huihua; Li, Wei; Teng, Yuee; Lu, Yen-Shen; Tseng, Ling-Ming; Yan, Min; Li, Hongsheng; Pang, Danmei; -Chen, Shin-Cheh; Chen, Wenyan; Jiang, Ou; Wang, Jingfen; Wu, Xinhong; Wang, Xian; Zang, Aimin; Wang, Xiaojia; Collins, Julie M; Fan, Ethan; Jiang, Lin; Zeng, Xiaoling; Turner, Nicholas C
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Real-world outcomes of everolimus-based treatment in a Taiwanese cohort with metastatic HR+/HER2- breast cancer

依维莫司治疗转移性HR+/HER2-乳腺癌患者在台湾人群中的真实世界疗效

期刊:
影响因子:
doi:10.1097/JCMA.0000000000001189
Kao, Yun-Chieh; Tsai, Yi-Fang; Shen, Shih-Che; Dai, Ming-Shen; Chen, Fang-Ming; Liu, Liang-Chih; Chao, Ta-Chung; Huang, Chi-Cheng; Hou, Ming-Feng; Chen, Shin-Cheh; Liu, Chun-Yu; Tseng, Ling-Ming
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Whole-Brain Radiotherapy Alone vs Preceded by Bevacizumab, Etoposide, and Cisplatin for Untreated Brain Metastases From Breast Cancer: A Randomized Clinical Trial

单纯全脑放疗与先行贝伐珠单抗、依托泊苷和顺铂化疗治疗未经治疗的乳腺癌脑转移瘤：一项随机临床试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2023.5456
Chen, Tom Wei-Wu; Dai, Ming-Shen; Tseng, Ling-Ming; Chen, Shin-Cheh; Chao, Tsu-Yi; Chao, Ta-Chung; Chang, Yuan-Ching; Chiu, Chang-Fang; Liu, Chien-Ting; Lin, Ching-Hung; Liu, Chun-Yu; Chen, Ya-Fang; Chang, Dwan-Ying; Yu, Jyh-Cherng; Rau, Kun-Ming; Hsieh, Yao-Yu; Shen, Shih-Che; Huang, Shu-Min; Cheng, Ann-Lii; Lu, Yen-Shen
神经科学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

The influence of chronic renal insufficiency on multi-therapeutic modalities for breast cancer: a single-center experience

慢性肾功能不全对乳腺癌多疗法的影响：单中心经验

期刊:Breast Cancer
影响因子:2.9
doi:10.1007/s12282-023-01530-w
Hong, Yi-Wen; Kuo, I-Ming; Kuo, Wen-Ling; Yu, Chi-Chang; Shen, Shih-Che; Tsai, Hsiu-Pei; Chu, Chia-Hui; Ho, Hui-Yu; Lo, Yung-Feng; Chen, Shin-Cheh; Lin, Yung-Chang; Chien, Chih-Ying; Chou, Hsu-Huan
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial

帕博利珠单抗联合化疗后序贯帕博利珠单抗治疗早期三阴性乳腺癌患者：一项随机临床试验的二次分析

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2023.42107
Takahashi, Masato; Cortés, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kümmel, Sherko; Denkert, Carsten; Park, Yeon Hee; Im, Seock-Ah; Ahn, Jin-Hee; Mukai, Hirofumi; Huang, Chiun-Sheng; Chen, Shin-Cheh; Kim, Min Hwan; Jia, Liyi; Li, Xin Tong; Tryfonidis, Konstantinos; Karantza, Vassiliki; Iwata, Hiroji; Schmid, Peter
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

The clinical relevance of humoral immune responses to Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 and expression of Globo H in metastatic breast cancer

Globo H-KLH疫苗adagloxad simolenin (OBI-822)/OBI-821的体液免疫反应及其在转移性乳腺癌中的表达的临床意义

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-004312
Hung, Jung-Tung; Chen, I-Ju; Ueng, Shir-Hwa; Huang, Chiun-Sheng; Chen, Shin-Cheh; Chen, Mu-Yi; Lin, Yung-Chang; Lin, Chun-Yen; Campbell, Michael J; Rugo, Hope S; Yu, Alice L
肿瘤
肿瘤免疫
乳腺癌
免疫/内分泌
发表日期：2022
文献求助 收藏

Breast cancer larger than 2.5 cm with tumor-free radioisotope-hot sentinel nodes has higher risk of non-hot axillary lymph node metastasis

肿瘤直径大于2.5厘米且放射性同位素阳性前哨淋巴结未见肿瘤转移的乳腺癌患者，发生非阳性腋窝淋巴结转移的风险更高。

期刊:Biomedical Journal
影响因子:4.4
doi:10.1016/j.bj.2021.04.009
Liu, Yu-Ling; Kuo, Wen-Ling; Lo, Yong-Feng; Tsai, Hsiu-Pei; Shen, Shih-Che; Yu, Chi-Chang; Chou, Hsu-Huan; Chu, Chia-Huei; Chen, Shin-Cheh
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Factors Associated with Axillary Lymph Node Status in Clinically Node-Negative Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

接受新辅助化疗的临床淋巴结阴性乳腺癌患者腋窝淋巴结状态的相关因素

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14184451
Yu, Chi-Chang; Cheung, Yun-Chung; Ueng, Shir-Hwa; Lin, Yung-Chang; Kuo, Wen-Ling; Shen, Shih-Che; Lo, Yung-Feng; Chen, Shin-Cheh
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏